CRP and stage 5 chronic kidney disease: Despite the positive attitude towards the use of surrogate endpoints among all stakeholders, they did not consider most currently used surrogates such as blood pressure, HbA1c, albuminuria and CRP valid substitutes for end-stage renal disease and cardiovascular (CV) outcomes.